{"id":245861,"date":"2012-02-21T23:10:00","date_gmt":"2012-02-21T23:10:00","guid":{"rendered":"http:\/\/www.eugenesis.com\/sonic-sounds-depths-of-growth\/"},"modified":"2012-02-21T23:10:00","modified_gmt":"2012-02-21T23:10:00","slug":"sonic-sounds-depths-of-growth","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/sonic-sounds-depths-of-growth.php","title":{"rendered":"Sonic sounds depths of growth"},"content":{"rendered":"<p><p>      Testing times: But Sonic Healthcare is still growing strong.      Photo: Jim Rice    <\/p>\n<p>    PATHOLOGY and radiology group Sonic Healthcare expects to hit    its full-year pre-tax earnings target of 10-15 per cent growth    as it reaps the rewards of strong organic revenue growth,    market share gains in Australia and margin expansion in    Germany.  <\/p>\n<p>    Sonic also says it will expand its margins in North America    where its business has increased market share despite the weak    economic environment.  <\/p>\n<p>    Chief executive Colin Goldschmidt said yesterday pathology was    an &#039;&#039;absolute essential service&#039;&#039; in the healthcare sector and    Sonic had incredible infrastructure in Australia, Germany and    the US.  <\/p>\n<p>    Advertisement: Story continues below  <\/p>\n<p>    &#039;&#039;It really is a very nice position to be in going into the    future, despite the uncertainties of the global climate et    cetera,&#039;&#039; Dr Goldschmidt said. &#039;&#039;It&#039;s a sector that tends to be    shielded in some way from some of the downturns that occur in    other sectors because it is an essential service.&#039;&#039;  <\/p>\n<p>    Sonic, which also has healthcare businesses in New Zealand,    Belgium and Switzerland, has posted a 6 per cent lift in    interim net profit to $143 million, or in constant-currency    terms up 8 per cent to $146 million.  <\/p>\n<p>    Statutory revenue was 9 per cent better at $1.64 billion, but    up 12 per cent to $1.69 billion in constant-currency terms.  <\/p>\n<p>    The company has declared an interim dividend of 24\u00a2 a share,    which is unchanged from the previous year.  <\/p>\n<p>    Dr Goldschmidt said headwinds from the strong Australian dollar    had softened the company&#039;s results, but did not affect    underlying performance.  <\/p>\n<p>    &#039;&#039;In a time of global uncertainty and weak economic conditions,    Sonic&#039;s operations continue to perform strongly, taking market    share from competitors and increasing margins,&#039;&#039; Dr Goldschmidt    said.  <\/p>\n<p>    Sonic was on track to deliver growth in earnings before    interest, tax, depreciation and amortisation of 10-15 per cent    over the 2010-11 level of $570 million, he said.  <\/p>\n<\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.businessday.com.au\/business\/sonic-sounds-depths-of-growth-20120221-1tloy.html\" title=\"Sonic sounds depths of growth\">Sonic sounds depths of growth<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Testing times: But Sonic Healthcare is still growing strong. Photo: Jim Rice PATHOLOGY and radiology group Sonic Healthcare expects to hit its full-year pre-tax earnings target of 10-15 per cent growth as it reaps the rewards of strong organic revenue growth, market share gains in Australia and margin expansion in Germany.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/sonic-sounds-depths-of-growth.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-245861","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245861"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=245861"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245861\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=245861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=245861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=245861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}